Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009.

Oketani M, Ido A, Nakayama N, Takikawa Y, Naiki T, Yamagishi Y, Ichida T, Mochida S, Onishi S, Tsubouchi H; Intractable Hepato-Biliary Diseases Study Group of Japan.

Hepatol Res. 2013 Feb;43(2):97-105. doi: 10.1111/j.1872-034X.2012.01105.x.

PMID:
23409848
[PubMed]
2.

Fulminant hepatitis and late onset hepatic failure in Japan.

Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G; Intractable Liver Diseases Study Group of Japan.

Hepatol Res. 2008 Jul;38(7):646-57. doi: 10.1111/j.1872-034X.2008.00322.x. Epub 2008 Mar 5.

PMID:
18328067
[PubMed]
3.

Changing etiologies and outcomes of acute liver failure: A perspective from Japan.

Oketani M, Ido A, Tsubouchi H.

J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:65-71. doi: 10.1111/j.1440-1746.2010.06574.x. Review.

PMID:
21199516
[PubMed - indexed for MEDLINE]
4.

Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey.

Yamashiki N, Sugawara Y, Tamura S, Nakayama N, Oketani M, Umeshita K, Uemoto S, Mochida S, Tsubouchi H, Kokudo N.

Liver Transpl. 2012 Sep;18(9):1069-77. doi: 10.1002/lt.23469.

PMID:
22577093
[PubMed - indexed for MEDLINE]
Free Article
5.

Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey.

Sato S, Suzuki K, Takikawa Y, Endo R, Omata M; Japanese National Study Group of Fulminant Hepatitis.

Hepatol Res. 2004 Nov;30(3):155-161.

PMID:
15588781
[PubMed - as supplied by publisher]
6.

Indication criteria for liver transplantation for acute liver failure in Japan.

Mochida S.

Hepatol Res. 2008 Nov;38 Suppl 1:S52-5. doi: 10.1111/j.1872-034X.2008.00427.x.

PMID:
19125953
[PubMed]
7.

Autoimmune fulminant liver failure in adults: Experience in a Japanese center.

Fujiwara K, Yasui S, Tawada A, Okitsu K, Yonemitsu Y, Chiba T, Arai M, Kanda T, Imazeki F, Nakano M, Oda S, Yokosuka O.

Hepatol Res. 2011 Feb;41(2):133-41. doi: 10.1111/j.1872-034X.2010.00755.x.

PMID:
21269383
[PubMed]
8.

Clinical epidemiology of fulminant hepatitis in Japan.

Takikawa Y, Suzuki K.

Hepatol Res. 2008 Nov;38 Suppl 1:S14-8. doi: 10.1111/j.1872-034X.2008.00421.x.

PMID:
19125945
[PubMed]
9.

Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis.

Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K.

Hepatol Res. 2008 Oct;38(10):970-9. doi: 10.1111/j.1872-034X.2008.00368.x. Epub 2008 May 7.

PMID:
18462374
[PubMed]
10.

Severe and fulminant hepatitis of indeterminate etiology in a Japanese center.

Fujiwara K, Yasui S, Nakano M, Yonemitsu Y, Arai M, Kanda T, Fukuda Y, Oda S, Yokosuka O.

Hepatol Res. 2015 Jan 12. doi: 10.1111/hepr.12483. [Epub ahead of print]

PMID:
25582192
[PubMed - as supplied by publisher]
11.

Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.

Lee WC, Wu MJ, Cheng CH, Chen CH, Shu KH, Lian JD.

Am J Kidney Dis. 2001 Nov;38(5):1074-81.

PMID:
11684562
[PubMed - indexed for MEDLINE]
12.

MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure.

Novelli G, Rossi M, Pretagostini R, Poli L, Novelli L, Berloco P, Ferretti G, Iappelli M, Cortesini R.

Liver. 2002;22 Suppl 2:43-7.

PMID:
12220303
[PubMed - indexed for MEDLINE]
13.

Influence of TNF gene polymorphism in patients with acute and fulminant hepatitis.

Tsuchiya N, Tokushige K, Yamaguchi N, Hasegawa K, Hashimoto E, Yamauchi K, Shiratori K.

J Gastroenterol. 2004 Sep;39(9):859-66.

PMID:
15565405
[PubMed - indexed for MEDLINE]
14.

Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience.

Bismuth H, Azoulay D, Samuel D, Reynes M, Grimon G, Majno P, Castaing D.

Ann Surg. 1996 Dec;224(6):712-24; discussion 724-6.

PMID:
8968226
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases.

Pérez-Alvarez R, Díaz-Lagares C, García-Hernández F, Lopez-Roses L, Brito-Zerón P, Pérez-de-Lis M, Retamozo S, Bové A, Bosch X, Sanchez-Tapias JM, Forns X, Ramos-Casals M; BIOGEAS Study Group.

Medicine (Baltimore). 2011 Nov;90(6):359-71. doi: 10.1097/MD.0b013e3182380a76.

PMID:
22033451
[PubMed - indexed for MEDLINE]
16.

Treatment of subacute hepatitis B with lamivudine: a pilot study in Serbia.

Delić D, Nesić Z, Prostran M, Boricić I, Svirtlih N.

Vojnosanit Pregl. 2009 Mar;66(3):199-202.

PMID:
19341224
[PubMed - indexed for MEDLINE]
17.

Present status of fulminant hepatitis in Japan (1989-1991)

Muto Y.

Gastroenterol Jpn. 1993 Mar;28 Suppl 4:120-7. Review.

PMID:
8486223
[PubMed - indexed for MEDLINE]
18.

[Immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection].

Sato K.

Gan To Kagaku Ryoho. 2011 Feb;38(2):161-8. Review. Japanese.

PMID:
21368477
[PubMed - indexed for MEDLINE]
19.

Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.

Chu CM.

J Gastroenterol Hepatol. 2000 May;15 Suppl:E25-30.

PMID:
10921378
[PubMed - indexed for MEDLINE]
20.

Clinical features of fulminant hepatitis in Nagasaki Prefecture, Japan.

Kato Y, Nakata K, Omagari K, Kusumoto Y, Mori I, Furukawa R, Tanioka H, Tajima H, Yano M, Eguchi K.

Intern Med. 2001 Jan;40(1):5-8.

PMID:
11201371
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk